MedTrace Logo

Visual Perceptual Learning Based Digital Therapeutics for Visual Field Defect After Stroke

NCT05525949 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 93

Last updated 2023-11-13

No results posted yet for this study

Summary

This study evaluates the efficacy of visual perceptual learning for the treatment of visual field defect caused by brain disease. Half of participants will receive visual perceptual training using the VIVID Brain. The other half will not receive any training because there is no standard treatment for visual field defect caused by brain disease.

Conditions

  • Visual Fields Hemianopsia
  • Hemianopsia, Homonymous

Interventions

DEVICE

VIVID Brain

Participants receive visual perceptual training using the VIVID Brain software.

OTHER

No-treatment Control

No-treatment is administered during control period.

Sponsors & Collaborators

  • Nunaps Inc

    lead INDUSTRY

Principal Investigators

  • Gyeong-Moon Kim, MD, PhD · Samsung Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-19
Primary Completion
2023-08-11
Completion
2023-11-08

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05525949 on ClinicalTrials.gov